- Surgical topical hemostat ; Korean market app. 75 billion won (as of 2014) - Emerging market for bone hemostasis and hemostats for endo/laparoscopic use - Companion animal industry market : 900 billion won in Korea (as of 2012)
Market Growth
- Domestic mkt App. 120 billion won in 2019, Global mkt 5 billion US$ to 7 billion US$ (2019)
- Companion animal industry market :5.2 trillion won in Korea (as of 2020). 5.7 billion US$ in USA
Technological Power
- Biocompatible/biodegradable biomaterial platform technology - A wealth of commercialization experiences, Solid R&D networks
R&D strategy
- Selection of globally unsatisfied needs for technology and products - Solid global R&D networks based on worldwide market
Scalability of Business
- Products embodiment of various application types (gel, powder, sponge, et al.) - Always ready to cooperate with other medical or pharmaceutical companies on the R&D or marketing sector
Applicable Sector
- Convergence technology and Biomedical products based on biocompatible materials (Tissue engineering, 3D printing, drug delivery system)
